Webinar Archive
Do you prefer a particular topic for one of our next webinars? Contact us at education@gendx.com
Training and Materials
Allelic polymorphism of KIRs in JAK2V617F and CALR mutation driven myeloproliferative neoplasms
Prof. Milena Ivanova-Shivarova from the Department of Clinical Immunology, University Hospital Alexandrovska, Medical University Sofia, BulgariaLessons learned from a CDx study; A perspective from Regulatory and IVD
by James Lappin, Associate Director of Global Regulatory Compliance at ARC Regulatory, and Jules Petit, Project Manager CDx at GenDxThe ARTEMIA trial – Targeting Non-Small Cell Lung Cancer (NSCLC) with a Therapeutic Cancer Vaccine OSE2101
by Silvia Comis, MD, head of Clinical Development at OSE Immunotherapeutics, and Valentina Manzini, PhD, Project coordinator Companion DiagnosticsChallenges of HLA matching in a diverse population and how the HLA community can help
by Abeer Madbouly, PhD Principal Bioinformatics Scientist, Biotherapies Lead, Be the MatchSmall registries making the difference – The Dutch Matchis experience
by Eric Spierings, PhD, Associate Professor at the University Medical Center Utrecht and Medical Immunologist at MATCHIS, and Bert Elbertse, MSc, Manager Donor Relations & Communication at MATCHISAn epigenetic biomarker that predicts treatment success and allows personalized management in Crohn’s disease
by Prof. dr. Wouter de Jonge, Professor of Intestinal Disease at Amsterdam UMC and University Clinic BonnHLA gene-editing of DRβ1_04_01 – A therapy for rheumatoid arthritis
May 24, 2023by Christina Roark, PhD, F(ACHI)
Immunogenetics of KIR and their interactions with HLA class I
April 12, 2023by Professor John Trowsdale Cambridge, University of Cambridge
Chimerism testing with high sensitive qpcr: implications for the routine work and clinicians
February 1, 2023by Andreas Heinold PhD, Deputy head of the HLA Laboratory, Universitätsklinikum Essen
Population study of the province of Quebec through the lens of the Registry
November 23, 2022by William Lemieux PhD, Postdoctoral Research Fellow at RI-MUHC
The importance of stem cell donation (Chicago session)
September 13, 2022by Jason Dehn, MPH, CHTC Director, Vendor, and Biorepository Services at Be The Match foundation
The importance of stem cell donation (Amsterdam session)
September 13, 2022by Martijn Braakman MSc, Immunogenetic consultant - Expertise Center at Matchis
MICA is a novel Histocompatibility antigen in kidney transplantation
July 6, 2022by Seiamak Bahram , MD, PhD, Professor of Medicine (Immunology) at the Strasbourg University School of Medicine and Teaching Hospitals
Webinar – HLA dogmas True or False
June 23, 2022by Erik Rozemuller PhD, GenDx and Hanneke Merkens PhD, GenDx
Webinar – Accurate Blood Group Typing
March 8, 2022by Prof. Ellen van der Schoot
Webinar – Understanding swine histocompatibility & immunogenetics
February 23, 2022Sam Ho PhD
Webinar – Molecular HLA compatibility background, theory and application
January 19, 2022by Massimo Mangiola PhD
The changing perspectives on uterine immunity
November 10, 2021by Marilen Benner PhD
HLA Typing with PacBio – Achieving high quality results with a long read sequencer
by Sake van Wageningen PhD, Project Manager R&D at GenDxSomatic Mutation of HLA Genes in Blood Cancer
May 18, 2021by Helene R. McMurray, Ph.D. Director-in-Training, Tissue Typing Laboratory; Director, Cell Biology of Disease / Pathology Ph.D. Program
New findings on the HLA-related MR1 gene
March 23, 2021by Dr. John Trowsdale PhD, University of Cambridge and Sake van Wageningen PhD, GenDx
PIRCHE Epitope Matching in Kidney Transplantation: A Case Study
February 16, 2021by guest speakers Dr. Eric Spierings, Associate Professor, Director of the HLA tyssue typing lab UMC and Matthias Niemann, PIRCHE Director of Technology
New insights from high-resolution KIR sequencing in neurological disease
November 11,2020by guest speaker Dr. Jill A. Hollenbach Associate Professor Neurology at the UCSF Weill Institute for Neurosciences
Significance and detection of chimerism after hematopoietic stem cell transplantation
October 28, 2020by guest speaker Dr. Katarina Štingl Janković, University Hospital Centre Zagreb
Transitioning to NGS: Why, and what to consider?
July 8, 2020with Deborah Tsuyuki PhD, Technical Application Specialist at GenDx.
Towards defining the immunogenicity of HLA eplets
September 16, 2020by guest speakers G. Hoenger and Prof. S. Schaub, University of Basel
Daily practice in an HLA lab: dealing with HLA-DR, a complicated genetic region
May 20, 2020with guest speaker Dr. Brown, the associate director of the histocompatibility testing laboratory, and assistant professor of pathology and laboratory medicine, at the University of Pennsylvania.
Variability in HLA expression: Impact on histocompatibility assay interpretation and immunologic risk assessment
May 7, 2020with guest speaker Dr. Luis Hidalgo, associate Professor and Histocompatibility Lab Director at the University of Wisconsin School of Medicine and Public Health.
PIRCHE – Predicting Alloreactivity in Transplantation and Transfusion
Jan 22, 2020with guest speaker Dr Eric Spierings, Universitair Medisch Centrum Utrecht, NL
Monitoring HLA-loss at time of leukemia relapse after stem cell transplantation
Nov 12, 2019with guest speaker Prof. Katharina Fleischhauer, Universitatsklinikum Essen, DE
